Innovus Pharmaceuticals Inc. (fka INNV)

[TrueTrades]

no youll have to google fda anda review cycle and read up to understand what im talking about
basically the fda has 6 months from the time they begin their review of the application to make a response
jan 2015 in fluticare case
if they deny it for any reason and the co fixes the issue and resubmits it then the fda has another 6 months to respond
this can go back and forth until the fda finally approves it or sends a complete response letter or clr
a clr generally kills the submission and that is when most bios pr the info and the stock tanks
so im saying cos generally dont pr that they got a response from fda unless it is an end result response of either approval or clr
legitimate cos would offer an explanation of some kind to shareholders after 30 months but innv just does some other side deal